United States · FDA National Drug Code directory

Boneforce HP

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
43857-0591_a17db4ea-1075-4c45-8c9c-3c667443325a
Product NDC
43857-0591
Form
LIQUID
Composition / generic term
Calcarea Carbonica, Calcarea Fluorica, Calcarea Phosphorica, Hekla Lava, Hydrofluoricum Acidum, Rhus Tox, Silicea, Symphytum Officinale
Labeler
BioActive Nutritional, Inc.
Marketing category
UNAPPROVED HOMEOPATHIC
Marketing start / end (source format)
20210601
Source listing expiry
20271231

Source-listed ingredients

  • OYSTER SHELL CALCIUM CARBONATE, CRUDE — 30 [hp_X]/mL
  • CALCIUM FLUORIDE — 30 [hp_X]/mL
  • TRIBASIC CALCIUM PHOSPHATE — 30 [hp_X]/mL
  • HEKLA LAVA — 30 [hp_X]/mL
  • HYDROFLUORIC ACID — 30 [hp_X]/mL
  • TOXICODENDRON PUBESCENS LEAF — 30 [hp_X]/mL
  • SILICON DIOXIDE — 30 [hp_X]/mL
  • COMFREY ROOT — 30 [hp_X]/mL

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 mL in 1 BOTTLE, DROPPER (43857-0591-1) · 43857-0591-1

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →